ipo

The Hong Kong Stock Exchange has eased IPO public float requirements and has made reforms in the IPO price discovery process; it is also carrying out a further consultation; meanwhile, listings continue apace.

A core product for Type 2 diabetes is expected to commercially launch in mainland China by the end of this year, subject to regulatory approval; CICC led the transaction.

The Hong Kong-headquartered Asian life insurer, backed by billionaire Richard Li, has made several similar filings in recent years without triggering an IPO.

Minority owner Partners Group said the IPO proceeds will be used to further grow the Hangzhou-headquartered restaurant's 493 outlets and establish a centralised food processing facility; Clifford Chance, Citi and CMB International Capital were involved in the deal.

The first 'pure-play' electric vehicle manufacturer to IPO on the Indian market is the largest listing this year in the country, while baby-product firm Brainbees Solutions has also listed; both have seen their shares soar on debut.

A strong debut last week by jewellery retailer Laopu Gold has put the spring back into the step of Hong Kong’s hitherto lacklustre IPO market. Can it last?

Geopolitics, interest rates and investor appetite will continue to weigh on the city’s bourse, lagging US peers along its IPO recovery journey. Meanwhile, from September, traders will be able to trade during typhoons.

Dealmakers in Asia are looking closely at China tech stocks – in particular spin-offs from giants such as JD.com and Alibaba – to lead a regional capital markets comeback.

The well-known law firm welcomes Nicholas Chua as new partner, bolstering its expertise in banking, capital markets and corporate finance both in Hong Kong and across the region.